About Us

About Us 2018-01-08T18:23:24+00:00

Technology

Aerin’s advanced treatment platform utilizes low-power radiofrequency energy to remodel nasal soft tissues and address the underlying cause of nasal congestion. Treatment styluses are uniquely designed for each procedure and deliver energy to the target tissue surface without the need for incisions or tissue penetration.  Proprietary algorithms ensure that targeted tissues are exposed to carefully controlled energy resulting in treatment temperatures that are below the tissue ablation range.  The technology is protected by a comprehensive patent estate consisting of both method and design patents.

Board of Directors

Greg Garfield – Chairman of the Board

Greg Garfield currently serves as Head of Medical Technology Investments for the KCK Group. Previously, Greg was the General Manager of Laryngology and Emerging Therapies for J&J’s Acclarent subsidiary, which J&J purchased for $800M. Prior to this role, Greg served as Acclarent’s Chief Operating Officer focusing on developing and commercializing products for use by ENT physicians to improve and enhance patients’ lives. Greg has many years of experience in the medical technology industry in a variety of roles.

Fred Dinger – CEO and President

Fred Dinger has over 25 years of experience with both large and small medical device companies. Prior to Aerin Medical, Fred served as President and Chief Executive Officer at ENTrigue Surgical, C2M Medical and OsteoBiologics, and has held leadership positions with A-Med Systems, where he served as Vice President and Chief Operating Officer, as well as Linvatec Corporation and Xomed Surgical Products, where Fred served as Vice President of Research and Development. Fred earned a Bachelor of Science in Mechanical Engineering from Cornell University and a Master of Science in Engineering Management from University of South Florida.

Scott Wolf, MD – Founder and Chief Medical Officer

Dr. Scott Wolf is a prolific medical device entrepreneur across a broad range of therapeutic areas. Scott founded Aerin Medical to create a non-surgical therapy to meet the enormous need of patients with nasal obstruction. Prior to founding Aerin Medical, Scott founded Zeltiq Aesthetics, the maker of CoolSculpting, the leading non-invasive method of fat reduction for bodysculpting. Scott’s other startups include Endogastric Solutions and Cardiac Dimensions. Scott was previously a partner at Prospect Venture Partners and a vice-president at Frazier Healthcare Ventures, both leading life science venture capital firms. Scott received his M.D. from George Washington University and his B.A. from the University of Pennsylvania.

Kern Bhugra – Board Member

Kern Bhugra has over 20 years of executive management experience in both start-ups and large corporations. Currently, Kern is the President of Leonis Medical Corporation, a medical device company whose mission is to support design and development of innovative medical technologies to improve patient quality of life. He serves on the Board of Directors for Leonis Medical and Aerin Medical as well as a non-profit educational institution in Northern California. Previously, Kern cofounded Tibion Bionic Technologies, and founded two additional companies in the medical device space. Kern received a BSEE with honors from the University of Michigan and a MSEE with emphasis in bioengineering from Stanford University.

Bill Facteau – Board Member

Bill Facteau is a medical device executive with 25 years’ experience. He currently is the President and CEO of Earlens, Corp, which is focused on transforming the hearing aid industry with its novel and proprietary light based technology.

Prior to joining Earlens Mr. Facteau served as President and CEO of Acclarent, the company that created Balloon Sinuplasty which was ultimately acquired by JNJ for $800M. Mr. Facteau has served as a Board Director on a number of successfully acquired ventures including Acclarent, Neotract, CVI, Cabachon, and ExploraMed.

Valeska Schroeder, PhD – Board Member

Valeska has been a Managing Director of KCK’s Medical Technologies Investment Group since 2016. KCK is a single-family fund investing in a range of industries in private equity, growth capital, and venture capital, including a focus in medical technology. Valeska is a member of the boards of two KCK portfolio companies, Aerin Medical and BioInspire. Before joining KCK, Valeska held roles in product development, program management, and marketing in medical device companies, including VitalConnect, Acclarent, and NDC. Valeska obtained a BS, MS, and PhD from University of California at Berkeley in Materials Science and Engineering.

Contact us

Email: info@aerinmedical.com
Phone: 678-892-1194

USA

Aerin Medical Inc.
232 E. Caribbean Drive
Sunnyvale, CA 94089 USA

Singapore

Aerin Medical Singapore Pte Ltd.
60 Albert Street,
#16-01, Singapore 189969